BUDGET IMPACT OF A BLOOD-BASED AUTO-ANTIBODY TEST TO UP-CLASSIFY RISK OF PULMONARY NODULES IN A US COMMERCIAL PAYER SETTING

被引：0
|
作者：
Smith, M. [1 ]
Campbell, D. [2 ]
Le, K. [3 ]
Migliaccio-Walle, K. [4 ]
Kang, A. [5 ]
Springmeyer, S. [5 ]
机构：
[1] Frederick Reg Hosp, Frederick, MD USA
[2] Curta Inc, South Kingstown, RI USA
[3] Biodesix Inc, Spring Hill, FL USA
[4] Curta Inc, Seattle, WA USA
[5] Biodesix Inc, Boulder, CO USA
来源：
VALUE IN HEALTH | 2023年 / 26卷 / 06期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
EE275
引用
收藏
页码：S109 / S109
页数：1
相关论文
共 6 条
  • [1] BUDGET IMPACT OF A BLOOD-BASED AUTO-ANTIBODY TEST TO UP-CLASSIFY RISK OF PULMONARY NODULES IN A US MEDICARE PAYER SETTING
    Smith, M.
    Campbell, D.
    Le, K.
    Migliaccio-Walle, K.
    Kang, A.
    Springmeyer, S.
    VALUE IN HEALTH, 2023, 26 (06) : S130 - S131
  • [2] BUDGET IMPACT OF A BLOOD-BASED INTEGRATED CLASSIFIER TEST TO RECLASSIFY RISK OF PULMONARY NODULES IN A US COMMERCIAL PAYER SETTING
    Smith, M.
    Le, K.
    Campbell, D.
    Migliaccio-Walle, K.
    Kang, A.
    Springmeyer, S.
    VALUE IN HEALTH, 2023, 26 (06) : S88 - S88
  • [3] EE38 BUDGET IMPACT OF A BLOOD-BASED INTEGRATED CLASSIFIER TEST TO DOWN CLASSIFY RISK OF PULMONARY NODULES IN A US MEDICARE PAYER SETTING
    Smith, M.
    Le, K.
    Campbell, D.
    Migliaccio-Walle, K.
    Kang, A.
    Springmeyer, S.
    VALUE IN HEALTH, 2023, 26 (06) : S66 - S66
  • [4] IMPACT OF A BLOOD-BASED RISK CLASSIFIER ON MANAGEMENT OF BENIGN PULMONARY NODULES IN A REAL-WORLD OBSERVATIONAL STUDY
    Pritchett, Michael
    Sigal, Barry
    Bowling, Mark
    Morganroth, Melvin
    Bernstein, Michael
    Seaman, Joseph
    Gordon, Joshiah
    Shah, Archan
    Kurman, Jonathan
    Romero, Arthur
    Tabassomi, Mostafa
    Aragaki, Alejandro
    Berry, Donald
    Biswas, Abhishek
    Bansal, Sandeep
    Pitcher, Trevor
    Peek, Laura
    Springmeyer, Steven
    CHEST, 2021, 160 (04) : 2536A - 2538A
  • [5] ECONOMIC IMPACT MODEL TO ESTIMATE THE VALUE OF BLOOD-BASED BIOMARKERS IN THE RISK ASSESSMENT OF PULMONARY NODULES (PNS) FROM A HEALTH SYSTEM PERSPECTIVE
    O'day, K.
    Li, Q.
    Dupont, T.
    Iranitalab, R.
    Le, K.
    VALUE IN HEALTH, 2024, 27 (12)
  • [6] First Look at the Distribution of Risk of Malignancy Pre and Post-Test Using a Blood-Based Biomarker in Patients with Pulmonary Nodules in a Real-World Observational Study
    Pritchett, M.
    Sigal, B. W.
    Bowling, M. R.
    Morganroth, M. L.
    Bernstein, M. A.
    Shah, A.
    Seaman, J.
    Gordon, J.
    Nakahodo, A. Aragaki
    Romero, A. O.
    Kurman, J. S.
    Berry, D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
1